Afatinib Active Not Recruiting Phase 2 Trials for Focus of Study Instead Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01728818Afatinib as Cancer Therapy for Exocrine Pancreatic Tumours